What is finerenone?
It is a non-steroidal mineralocorticoid receptor antagonist. According to the BNF it “inhibits receptor-mediated sodium reabsorption and decreases receptor overactivation, thereby reducing the inflammation and fibrosis that lead to kidney damage”.
Why is CKD such an issue for people with T2DM?
This is summarised from what Nice has put in their guideline.